GENETICALLY-DETERMINED POLYMORPHISMS IN DRUG OXIDATION

被引：104

作者：

JACQZ, E ^{[1
]}

HALL, SD ^{[1
]}

BRANCH, RA ^{[1
]}

机构：

[1] VANDERBILT UNIV, MED CTR, SCH MED, DIV CLIN PHARMACOL, NASHVILLE, TN 37232 USA

来源：

关键词：

D O I：

10.1002/hep.1840060534

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1020 / 1032

页数：13

共 128 条

[91] Ritchie J C, 1980, Ciba Found Symp, V76, P219
[92] RODEN DM, 1982, J PHARMACOL EXP THER, V221, P552
[93] ROWLAND M, 1980, CLIN PHARMACOKINET, P124
[94] METABOLISM OF METHOXYPHENAMINE IN EXTENSIVE AND POOR METABOLIZERS OF DEBRISOQUIN
ROY, SD
HAWES, EM
MCKAY, G
KORCHINSKI, ED
MIDHA, KK
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) : 128 - 133
[95] SCHIMKE RT, 1984, CANCER RES, V44, P1735
[96] POLYMORPHIC DEXTROMETHORPHAN METABOLISM - CO-SEGREGATION OF OXIDATIVE O-DEMETHYLATION WITH DEBRISOQUIN HYDROXYLATION
SCHMID, B
BIRCHER, J
PREISIG, R
KUPFER, A
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (06) : 618 - 624
[97] PHARMACOGENETICS OF TOLBUTAMIDE METABOLISM IN HUMANS
SCOTT, J
POFFENBARGER, PL
[J]. DIABETES, 1979, 28 (01) : 41 - 51
[98] Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100
[99] SHAH RR, 1980, LANCET, V1, P1147
[100] SHAH RR, 1982, BRIT MED J, V284, P408